Back to Search
CAROLYN KLEBANOFF, MD
MD
Internal Medicine Physician
NPI: 1093892846Individual
Specialties, Licenses & Credentials
Research & Publications (14)
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.
PMID 19561320·Blood·2009
7-preclinical
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.
PMID 15980149·Proc Natl Acad Sci U S A·2005
4-observational
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.
PMID 15668127·Trends Immunol·2005
6-review
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
PMID 14762166·Proc Natl Acad Sci U S A·2004
7-preclinical
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity.
PMID 18523011·Proc Natl Acad Sci U S A·2008
7-preclinical
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
PMID 18276844·Blood·2008
7-preclinical
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
PMID 16621991·J Immunol·2006
7-preclinical
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
PMID 16203864·J Exp Med·2005
4-observational
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.
PMID 15931392·J Clin Invest·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3000 COLBY, #200
BERKELEY, CA 94705 - Phone
- (510) 848-7977
Quick Facts
- NPI
- 1093892846
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile